CoChat

Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles’ antifungal activities

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index; 20 of the 26 sources its claims cite were checked for support.

Abstract

Azole effectiveness against candidiasis can be compromised by Candida albicans resistance and tolerance, and unfortunately, few clinically useful compounds can enhance azole antifungal activities. We find that the amino acids V234, F235 and L238 of Erg11 are critical for its interaction with Ncp1, and the Ncp1-Erg11 association is important in azole response. Ellipticine and its analog phiKan 083 block this Erg11-Ncp1 interaction by targeting Ncp1, and boost antifungal effects of fluconazole in vitro and in vivo. A series of steps influencing this process—an initial elevation in reactive oxygen species, leading to protein oxidation and misfolding in the endoplasmic reticulum (ER) that causes ER stress. This stress leads to Ca2+ release from the ER, mitochondrial Ca2+ accumulation and dysfunction, increased ROS production, and apoptosis of C. albicans cells. Overall, disrupting the Erg11-Ncp1 interaction in C. albicans can serve as a useful approach to enhancing the antifungal properties of azoles. In this work, authors mechanistically explore the impact of the disruption of the Erg11-Ncp1 interaction in Candida albicans. Subsequent cellular stress releases calcium and damages mitochondria, increasing toxic oxidative molecules, and leading fungal cells to self-destruct. These reactions may serve as an approach to enhance antifungal properties of azoles.

Overview

CoChat Summary

## TL;DR

This study shows that disrupting the Erg11–Ncp1 interaction in *Candida albicans* makes azoles more effective, with V234, F235, and L238 in Erg11 identified as key interface residues. Ellipticine, and its analog phiKan 083, inhibit this interaction and enhance fluconazole (FLC) activity in vitro and in animal infection models.

## Key findings

  • The Erg11–Ncp1 interaction depends on the Erg11 200–251 region and the Ncp1 1–63 region; fragment analyses showed Erg11 1–200 could not interact with Ncp1, while Erg11 1–251 could.
  • Molecular dynamics predicted V234, F235, and L238 as the most important Erg11 residues for binding, and alanine substitutions at these positions abolished interaction in MYTH and co-IP assays.
  • Disrupting the interaction increased azole susceptibility: the erg11m/erg11Δ mutant was more susceptible to fluconazole, miconazole, voriconazole, ketoconazole, and itraconazole, with lower MIC and SMG for FLC than wild type; FLC plus ergosterol did not rescue this mutant.
  • The mechanism traced from ER stress to apoptosis: misfolded proteins increased by 29 ± 1.4% without FLC and 73 ± 5.3% with 4 μg/mL FLC; ROS rose by 35 ± 0.5%; mitochondrial Ca2+ was 6.9 ± 1.1-fold higher; apoptosis increased to 10.5 ± 0.3% versus 3.4 ± 0.5% in the control strain.
  • Ellipticine inhibited the Erg11–Ncp1 interaction, decreasing the Ncp1/Erg11 co-IP ratio to 64 ± 8.3%, and in combination with FLC caused 2.6 ± 0.1-fold higher intracellular ROS, 23.9 ± 1.1% apoptosis, and a 41.2 ± 8.8% drop in mitochondrial membrane potential.
  • In vivo, ellipticine improved FLC efficacy in *Galleria mellonella* (survival difference vs controls reported as p = 0.0003, p = 0.0021, and p < 0.0001 against the three comparison groups), and phiKan 083 also enhanced FLC activity, with 60% survival in larvae versus 100% mortality in the other groups.

## Methods

  • The study combined MYTH assays, co-immunoprecipitation, molecular dynamics simulations, DARTS, RNA-seq, flow cytometry, confocal microscopy, and antifungal susceptibility testing to map the Erg11–Ncp1 interaction, test mutants, and evaluate candidate inhibitors.
  • Functional tests used *C. albicans* wild-type and engineered strains including erg11m/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ; animal work included Galleria mellonella infection models and a C57BL/6 mouse systemic candidiasis model.
  • Main analyses included MIC, SMG, FICI, growth curves, ROS/misfolded-protein/Ca2+/mitochondrial-potential/apoptosis readouts, and survival analysis with the log-rank test.

## Limitations

  • The paper states that the enhancement effect of ellipticine on FLC in the murine systemic candidiasis model was suboptimal, which it attributes to inadequate pharmacokinetic parameters of ellipticine.
  • The authors note that Erg11 and Ncp1 are membrane-anchored proteins, making expression, purification, and crystallization difficult; therefore, the study did not perform structure–activity relationship analysis for ellipticine analogs.
  • Evident from the text: much of the mechanistic work relies on engineered mutants and in vitro assays, so direct evidence of the proposed pathway in humans or natural infection contexts is not stated in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-025-62131-z

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The Erg11200-251 region and the Ncp11-63 region are important for the Erg11-Ncp1 interaction. a The schematic diagram of a membrane yeast two-hybrid (MYTH) system. b MYTH analyzed the interaction between Erg11 and Ncp1. “Erg11” refers to yeast cells transformed with the bait Erg11 and the empty prey vector. “Erg11 + Ncp1” denotes the co-transformation of both the bait Erg11 and the prey Ncp1 into yeast cells. “Positive control” denotes the co-transformation of both the bait APP and the prey Fe65. “Negative control” refers to yeast cells that have been transformed with the bait APP and the prey vector without any protein insertions. c Co-IP assay analyzed the interaction between Erg11 and Ncp1. “Input” refers to lysates without any other manipulations used for immunoblotting. “IP” stands for immunoprecipitate, and the Protein A columns are used to collect the antibody-protein complex. “+“ indicates co-incubation of lysates with anti-Myc or anti-HA antibody, and “−“ represents lysates not incubated with antibodies. d Spotting assays of the yeast cells co-transformed to Ncp1 and C-terminal truncated fragments of Erg11. “Erg111-x “ represents the retained amino acids of Erg11. The schematic diagram depicts the interception strategy utilized to investigate the crucial interaction regions of Erg11. e Co-IP assay analyzed the interaction between Ncp1 and Erg111-251 or Erg111-200. The upper panel precipitates Erg111-251 with anti-Myc antibody and Ncp1 with anti-HA antibody. The lower panel precipitates Erg111-200 with anti-Myc antibody and Ncp1 with anti-HA antibody. f Spotting assays of the yeast cells containing Erg11 and N-terminal truncated fragments of Ncp1. “Ncp1y-680” represents the retained amino acids of Ncp1. g Co-IP assay analyzed the interaction between Erg11 and Ncp163-680 or Ncp191-680. The experiment was repeated three times with similar results. Source data, including uncropped and unprocessed scans with molecular weight markers are provided as Source Data file (c, e, g).
Fig. 1 The Erg11200-251 region and the Ncp11-63 region are important for the Erg11-Ncp1 interaction. a The schematic diagram of a membrane yeast two-hybrid (MYTH) system. b MYTH analyzed the interaction between Erg11 and Ncp1. “Erg11” refers to yeast cells transformed with the bait Erg11 and the empty prey vector. “Erg11 + Ncp1” denotes the co-transformation of both the bait Erg11 and the prey Ncp1 into yeast cells. “Positive control” denotes the co-transformation of both the bait APP and the prey Fe65. “Negative control” refers to yeast cells that have been transformed with the bait APP and the prey vector without any protein insertions. c Co-IP assay analyzed the interaction between Erg11 and Ncp1. “Input” refers to lysates without any other manipulations used for immunoblotting. “IP” stands for immunoprecipitate, and the Protein A columns are used to collect the antibody-protein complex. “+“ indicates co-incubation of lysates with anti-Myc or anti-HA antibody, and “−“ represents lysates not incubated with antibodies. d Spotting assays of the yeast cells co-transformed to Ncp1 and C-terminal truncated fragments of Erg11. “Erg111-x “ represents the retained amino acids of Erg11. The schematic diagram depicts the interception strategy utilized to investigate the crucial interaction regions of Erg11. e Co-IP assay analyzed the interaction between Ncp1 and Erg111-251 or Erg111-200. The upper panel precipitates Erg111-251 with anti-Myc antibody and Ncp1 with anti-HA antibody. The lower panel precipitates Erg111-200 with anti-Myc antibody and Ncp1 with anti-HA antibody. f Spotting assays of the yeast cells containing Erg11 and N-terminal truncated fragments of Ncp1. “Ncp1y-680” represents the retained amino acids of Ncp1. g Co-IP assay analyzed the interaction between Erg11 and Ncp163-680 or Ncp191-680. The experiment was repeated three times with similar results. Source data, including uncropped and unprocessed scans with molecular weight markers are provided as Source Data file (c, e, g).CC BY-NC-ND · PubMed Central
Fig. 2 Amino acid residues V234, F235, and L238 in Erg11 contribute to the Erg11 -Ncp1 interaction. a The energy decomposition diagram for the Erg11200-251 region revealed that the residues V234, F235, and L238 exhibited the highest energy contributions, with ΔGbind values of −0.85 kcal/mol, −1.95 kcal/mol, and −2.04 kcal/mol, respectively. b The MYTH system analyzed the interaction between Erg11m and Ncp1. “Erg11m” represents the yeast cells with the bait Erg11m and the prey vector (no inserting Ncp1); “Erg11m + Ncp1” is the co-transformation of the bait Erg11 and the prey Ncp1 to the yeast cells. c Co-IP assay analyzed the interaction between Erg11m and Ncp1. An anti-Myc antibody to precipitate Erg11m or Erg11 and utilizes an anti-HA antibody to precipitate Ncp1. The protein content of 3HA-Ncp1 was quantified relative to Erg11m-13Myc or Erg11-13Myc. “Input” refers to lysates without any other manipulations used for immunoblotting. “IP” stands for immunoprecipitate, and the Protein A columns are used to collect the antibody-protein complex. “+“ indicates co-incubation of lysates with anti-Myc antibody, and “−“ represents lysates not incubated with antibodies. d Co-IP assay analyzed the interaction between Erg11m and Ncp1. An anti-HA antibody to precipitate Ncp1. The protein content of Erg11m-13Myc or Erg11-13Myc was quantified relative to 3HA-Ncp1. “+“ indicates co-incubation of lysates with anti-HA antibody, and “−“ represents lysates not incubated with antibodies. Three biological replicates were carried out. One of the representative images is shown (c, d). Data were presented as mean ± standardized variance (SD) (n = 3). Two-tailed unpaired t-test (c, d). Source data including uncropped and unprocessed scans with molecular weight markers are provided as Source Data file (c, d).
Fig. 2 Amino acid residues V234, F235, and L238 in Erg11 contribute to the Erg11 -Ncp1 interaction. a The energy decomposition diagram for the Erg11200-251 region revealed that the residues V234, F235, and L238 exhibited the highest energy contributions, with ΔGbind values of −0.85 kcal/mol, −1.95 kcal/mol, and −2.04 kcal/mol, respectively. b The MYTH system analyzed the interaction between Erg11m and Ncp1. “Erg11m” represents the yeast cells with the bait Erg11m and the prey vector (no inserting Ncp1); “Erg11m + Ncp1” is the co-transformation of the bait Erg11 and the prey Ncp1 to the yeast cells. c Co-IP assay analyzed the interaction between Erg11m and Ncp1. An anti-Myc antibody to precipitate Erg11m or Erg11 and utilizes an anti-HA antibody to precipitate Ncp1. The protein content of 3HA-Ncp1 was quantified relative to Erg11m-13Myc or Erg11-13Myc. “Input” refers to lysates without any other manipulations used for immunoblotting. “IP” stands for immunoprecipitate, and the Protein A columns are used to collect the antibody-protein complex. “+“ indicates co-incubation of lysates with anti-Myc antibody, and “−“ represents lysates not incubated with antibodies. d Co-IP assay analyzed the interaction between Erg11m and Ncp1. An anti-HA antibody to precipitate Ncp1. The protein content of Erg11m-13Myc or Erg11-13Myc was quantified relative to 3HA-Ncp1. “+“ indicates co-incubation of lysates with anti-HA antibody, and “−“ represents lysates not incubated with antibodies. Three biological replicates were carried out. One of the representative images is shown (c, d). Data were presented as mean ± standardized variance (SD) (n = 3). Two-tailed unpaired t-test (c, d). Source data including uncropped and unprocessed scans with molecular weight markers are provided as Source Data file (c, d).CC BY-NC-ND · PubMed Central
Fig. 3 Impairing the Erg11-Ncp1 interaction enhances the susceptibility of C. albicans to azoles. a The schematic diagram illustrating the generation of the erg11m/erg11Δ mutant involved the insertion of synthesized Erg11m at the ADE2 gene locus in the heterozygous deleted mutant ERG11/erg11Δ. Subsequently, the ARG4 gene was employed to replace the remaining allele of the ERG11 gene, resulting in the creation of the erg11m/erg11Δ mutant, where Erg11m and Ncp1 were found to be incapable of interacting. b Spotting assays were conducted to assess the hypersensitivity of the erg11m/erg11Δ mutant to fluconazole (FLC) in comparison to the wild-type strain SN152 and the ERG11/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ mutants on YPD plates with or without 4 μg/mL FLC. Images of the cultured cells were captured after 48 h of incubation at 30 °C. c The FLC disk diffusion assays were conducted on the erg11m/erg11Δ mutant, which exhibited a larger and cleaner inhibition zone on plates compared to the wild-type strain SN152 and the mutants of ERG11/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ. d The MIC assays were conducted to evaluate the hypersensitivity of the erg11m/erg11Δ mutant to FLC contrasted with the wild-type strain SN152 and the mutants of ERG11/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ. “NA” stands for “not applicable”. e The MIC assays demonstrated that ergosterol was ineffective in completely mitigating the antifungal effects of FLC in the erg11m/erg11Δ mutant. “NA” stands for “not applicable”. Source data are provided as a Source Data file.
Fig. 3 Impairing the Erg11-Ncp1 interaction enhances the susceptibility of C. albicans to azoles. a The schematic diagram illustrating the generation of the erg11m/erg11Δ mutant involved the insertion of synthesized Erg11m at the ADE2 gene locus in the heterozygous deleted mutant ERG11/erg11Δ. Subsequently, the ARG4 gene was employed to replace the remaining allele of the ERG11 gene, resulting in the creation of the erg11m/erg11Δ mutant, where Erg11m and Ncp1 were found to be incapable of interacting. b Spotting assays were conducted to assess the hypersensitivity of the erg11m/erg11Δ mutant to fluconazole (FLC) in comparison to the wild-type strain SN152 and the ERG11/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ mutants on YPD plates with or without 4 μg/mL FLC. Images of the cultured cells were captured after 48 h of incubation at 30 °C. c The FLC disk diffusion assays were conducted on the erg11m/erg11Δ mutant, which exhibited a larger and cleaner inhibition zone on plates compared to the wild-type strain SN152 and the mutants of ERG11/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ. d The MIC assays were conducted to evaluate the hypersensitivity of the erg11m/erg11Δ mutant to FLC contrasted with the wild-type strain SN152 and the mutants of ERG11/erg11Δ, NCP1/ncp1Δ, erg11Δ/erg11Δ, and ncp1Δ/ncp1Δ. “NA” stands for “not applicable”. e The MIC assays demonstrated that ergosterol was ineffective in completely mitigating the antifungal effects of FLC in the erg11m/erg11Δ mutant. “NA” stands for “not applicable”. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 4 Impairing the Erg11-Ncp1 interaction triggers ER stress. a Go pathway enrichment analysis using RNA-seq to compare the transcriptome data of the ERG11/erg11Δ and erg11m/erg11Δ mutants after 16 h at 30 °C. The Q-value, which is the P-value adjusted for multiple hypothesis testing, ranges from 0 to 1. A lower Q-value indicates a higher level of significance in terms of enrichment. The Rich Ratio is calculated as the ratio of differentially expressed genes within a pathway term to all annotated genes within that pathway term. b Cellular levels of ROS were measured in the absence of drug treatment and following treatment with 8 μg/mL menadione for 4 h. c Quantification of cellular misfolded proteins was conducted by treating mutants ERG11/erg11Δ and erg11m/erg11Δ without or with 4 μg/mL FLC. d The mRNA expression of the HAC1 and IRE1 genes in the absence or presence of 4 μg/mL FLC for 4 h was quantified. The mutant ERG11/erg11Δ was treated with 5 mM DTT for 2 h as the positive control. The ACT1 gene served as the control. Three biological replicates were carried out. Data were presented as mean ± SD (n = 3). Statistical analysis was performed using an unpaired two-tailed t test (b, c, d). Source data are provided as a Source Data file.
Fig. 4 Impairing the Erg11-Ncp1 interaction triggers ER stress. a Go pathway enrichment analysis using RNA-seq to compare the transcriptome data of the ERG11/erg11Δ and erg11m/erg11Δ mutants after 16 h at 30 °C. The Q-value, which is the P-value adjusted for multiple hypothesis testing, ranges from 0 to 1. A lower Q-value indicates a higher level of significance in terms of enrichment. The Rich Ratio is calculated as the ratio of differentially expressed genes within a pathway term to all annotated genes within that pathway term. b Cellular levels of ROS were measured in the absence of drug treatment and following treatment with 8 μg/mL menadione for 4 h. c Quantification of cellular misfolded proteins was conducted by treating mutants ERG11/erg11Δ and erg11m/erg11Δ without or with 4 μg/mL FLC. d The mRNA expression of the HAC1 and IRE1 genes in the absence or presence of 4 μg/mL FLC for 4 h was quantified. The mutant ERG11/erg11Δ was treated with 5 mM DTT for 2 h as the positive control. The ACT1 gene served as the control. Three biological replicates were carried out. Data were presented as mean ± SD (n = 3). Statistical analysis was performed using an unpaired two-tailed t test (b, c, d). Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 5 Impairing the Erg11-Ncp1 interaction leads to the release of Ca2+ from the ER and accumulation in the mitochondria. a Representative images depicting the localization of Ca2+ localization (green) in relation to ER membranes (red) were obtained from ERG11/erg11Δ and erg11m/erg11Δ mutants. Scale bar = 5 µm. b The integrated green fluorescence intensity (post-merge) was quantitatively analyzed between the ERG11/erg11Δ and erg11m/erg11Δ mutants using Image J software. The integrated fluorescence intensity was calculated as the product of the fluorescence density and the fluorescence area. c An assay was conducted to observe for Ca2+ activation (red) in the mitochondria using confocal microscopy. In the diagram provided, the large black ellipse symbolizes the C. albicans cell, the small orange ellipse represents the mitochondria, and the red dot signifies Ca2+. Scale bar = 5 µm. d The mitochondrial Ca2+ levels in confocal microscopy images were quantitatively analyzed between the ERG11/erg11Δ and erg11m/erg11Δ mutants using Image J software. The integrated fluorescence intensity was calculated as the product of the fluorescence density and the fluorescence area. Three biological replicates were performed, and a representative image is shown (a, c). Violin plots display the distribution density (width of the violin shape), median (black points), interquartile range (white points), and range (minimum and maximum values) (b, d). Two-tailed unpaired t-test (b, d). Source data are provided as a Source Data file.
Fig. 5 Impairing the Erg11-Ncp1 interaction leads to the release of Ca2+ from the ER and accumulation in the mitochondria. a Representative images depicting the localization of Ca2+ localization (green) in relation to ER membranes (red) were obtained from ERG11/erg11Δ and erg11m/erg11Δ mutants. Scale bar = 5 µm. b The integrated green fluorescence intensity (post-merge) was quantitatively analyzed between the ERG11/erg11Δ and erg11m/erg11Δ mutants using Image J software. The integrated fluorescence intensity was calculated as the product of the fluorescence density and the fluorescence area. c An assay was conducted to observe for Ca2+ activation (red) in the mitochondria using confocal microscopy. In the diagram provided, the large black ellipse symbolizes the C. albicans cell, the small orange ellipse represents the mitochondria, and the red dot signifies Ca2+. Scale bar = 5 µm. d The mitochondrial Ca2+ levels in confocal microscopy images were quantitatively analyzed between the ERG11/erg11Δ and erg11m/erg11Δ mutants using Image J software. The integrated fluorescence intensity was calculated as the product of the fluorescence density and the fluorescence area. Three biological replicates were performed, and a representative image is shown (a, c). Violin plots display the distribution density (width of the violin shape), median (black points), interquartile range (white points), and range (minimum and maximum values) (b, d). Two-tailed unpaired t-test (b, d). Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 6 The impaired Erg11-Ncp1 interaction leads to mitochondrial dysfunction. a Rhodamine 123 staining was utilized to observe alterations in mitochondrial membrane potential. A positive control group that the ERG11/erg11Δ mutant treated with 5 mM DTT for 2 h was included. b A quantitative analysis was conducted on mitochondrial ROS levels in the ERG11/erg11Δ and erg11m/erg11Δ mutants. A positive control group was included, consisting of the ERG11/e rg11Δ mutant incubated with 5 mM DTT for 2 h. c The fluorescence intensity of misfolded proteins within mitochondria was assessed using flow cytometry. A positive control group that the ERG11/erg11Δ mutant was treated with DTT was included. d Density plots were used to visualize the fluorescence patterns of the ERG11/erg11Δ and erg11m/erg11Δ mutants for 8 h. Data were obtained from three biological repeats, and representative images are shown. e Quantification of Annexin V/PI double staining assay. Data are mean ± SD of n = 3 biological replicates (a, c, e). Two-tailed unpaired t-tests were used (a, c, e). Source data are provided as a Source Data file.
Fig. 6 The impaired Erg11-Ncp1 interaction leads to mitochondrial dysfunction. a Rhodamine 123 staining was utilized to observe alterations in mitochondrial membrane potential. A positive control group that the ERG11/erg11Δ mutant treated with 5 mM DTT for 2 h was included. b A quantitative analysis was conducted on mitochondrial ROS levels in the ERG11/erg11Δ and erg11m/erg11Δ mutants. A positive control group was included, consisting of the ERG11/e rg11Δ mutant incubated with 5 mM DTT for 2 h. c The fluorescence intensity of misfolded proteins within mitochondria was assessed using flow cytometry. A positive control group that the ERG11/erg11Δ mutant was treated with DTT was included. d Density plots were used to visualize the fluorescence patterns of the ERG11/erg11Δ and erg11m/erg11Δ mutants for 8 h. Data were obtained from three biological repeats, and representative images are shown. e Quantification of Annexin V/PI double staining assay. Data are mean ± SD of n = 3 biological replicates (a, c, e). Two-tailed unpaired t-tests were used (a, c, e). Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 7 Ellipticine acts as an inhibitor of the Erg11-Ncp1 interaction. a Schematic of Erg11-Ncp1 inhibitor screening using MYTH. b Relative growth rates of six Erg11-Ncp1 interaction candidates measured by MYTH. c Dose-matrix assays of albicans cmp1-aidΔ/cmp1-aidΔ with ellipticine and FLC; DTT as positive control. d Growth inhibition curve assays were conducted to assess the combined effects of FLC and ellipticine. Data represent mean ± SD (n = 3). e Co-IP analysis shows ellipticine blocked the Erg11-Ncp1 interaction. “Input” is the Erg11-13Myc/3HA-Ncp1 lysate used for immunoblotting. “NC” is the wild-type SN152 lysate as a negative control. The binding rate of 3HA-Ncp1 to Erg11-13Myc was quantified. f Intracellular ROS was quantified after treatment with 16 μg/mL ellipticine and 4 μg/mL FLC. g Misfolded proteins in ERG11/erg11Δ mutants were analyzed after treatment with 16 μg/mL ellipticine and 4 μg/mL FLC. h Mitochondrial misfolded proteins were determined by MitoTracker Green. i Intracellular Ca2+ levels were quantified following treatment with 16 μg/mL ellipticine and 4 μg/mL FLC in the ERG11/erg11Δ mutant. j Mitochondrial membrane potential changes were assessed by Rhodamine 123 staining. k CYC3 gene expression was quantified after treatment with 16 μg/mL ellipticine and 4 μg/mL FLC. l Annexin V/PI double staining density plots were generated. m Quantification of Annexin V/PI double staining assay. n Ellipticine protects Ncp1 from pronase degradation in DARST assays. Uncropped, unprocessed scans with molecular weight markers are provided in the Source Data file. The quantification shows 3HA-Ncp1 protein levels in the control group relative to the ellipticine group. The representative images shown are from 3 biological repeats (e, I, n). Data were presented as mean ± SD of n = 3 biological replicates (b, e–k, m, n). Two-tailed unpaired t-test (b, e–k, m, n). Source data are provided as a Source Data file.
Fig. 7 Ellipticine acts as an inhibitor of the Erg11-Ncp1 interaction. a Schematic of Erg11-Ncp1 inhibitor screening using MYTH. b Relative growth rates of six Erg11-Ncp1 interaction candidates measured by MYTH. c Dose-matrix assays of albicans cmp1-aidΔ/cmp1-aidΔ with ellipticine and FLC; DTT as positive control. d Growth inhibition curve assays were conducted to assess the combined effects of FLC and ellipticine. Data represent mean ± SD (n = 3). e Co-IP analysis shows ellipticine blocked the Erg11-Ncp1 interaction. “Input” is the Erg11-13Myc/3HA-Ncp1 lysate used for immunoblotting. “NC” is the wild-type SN152 lysate as a negative control. The binding rate of 3HA-Ncp1 to Erg11-13Myc was quantified. f Intracellular ROS was quantified after treatment with 16 μg/mL ellipticine and 4 μg/mL FLC. g Misfolded proteins in ERG11/erg11Δ mutants were analyzed after treatment with 16 μg/mL ellipticine and 4 μg/mL FLC. h Mitochondrial misfolded proteins were determined by MitoTracker Green. i Intracellular Ca2+ levels were quantified following treatment with 16 μg/mL ellipticine and 4 μg/mL FLC in the ERG11/erg11Δ mutant. j Mitochondrial membrane potential changes were assessed by Rhodamine 123 staining. k CYC3 gene expression was quantified after treatment with 16 μg/mL ellipticine and 4 μg/mL FLC. l Annexin V/PI double staining density plots were generated. m Quantification of Annexin V/PI double staining assay. n Ellipticine protects Ncp1 from pronase degradation in DARST assays. Uncropped, unprocessed scans with molecular weight markers are provided in the Source Data file. The quantification shows 3HA-Ncp1 protein levels in the control group relative to the ellipticine group. The representative images shown are from 3 biological repeats (e, I, n). Data were presented as mean ± SD of n = 3 biological replicates (b, e–k, m, n). Two-tailed unpaired t-test (b, e–k, m, n). Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 8 Ellipticine and its analog phiKan 083 enhance the antifungal activity of FLC in vivo against C. albicans. a An investigation was conducted on the survival of animals exposed to ellipticine against the wild-type SN152 in Galleria mellonella (n = 10 per group). b An investigation was conducted on the survival of animals exposed to ellipticine in a highly FLC-tolerant C. albicans strain, cmp1-aidΔ/cmp1-aidΔ in Galleria mellonella (n = 10 per group). c The fungal load in the kidneys of phiKan 083 was conducted in C. albicans SN152 was assessed. n = 12 mice. d The CFUs analysis of phiKan 083 was conducted in the C. albicans strain cmp1-aidΔ/cmp1-aidΔ. n = 12 mice. e The histopathological examination of phiKan 083 in the C. albicans SN152 involved staining the kidneys of mice with PAS, followed by the display of representative images from 3 biological repeats. f The histopathological examination of phiKan 083 in the C. albicans strain cmp1-aidΔ/cmp1-aidΔ involved staining the kidneys of mice with PAS, followed by the display of representative images from 3 biological repeats. g An investigation into the survival of Galleria mellonella larvae (n = 10 per group) infected with the C. albicans SN152, specifically focusing on the impact of phiKan 083 treatment. h An investigation into the survival of Galleria mellonella larvae (n = 10 per group) infected with the highly FLC-tolerant C. albicans strain cmp1-aidΔ/cmp1-aidΔ, specifically focusing on the impact of phiKan 083 treatment. Data were presented as mean ± SD (c, d). Log-rank (Mantel-Cox) test (a, b, g, h), two-tailed unpaired t-test (c, d). Source data are provided as a Source Data file.
Fig. 8 Ellipticine and its analog phiKan 083 enhance the antifungal activity of FLC in vivo against C. albicans. a An investigation was conducted on the survival of animals exposed to ellipticine against the wild-type SN152 in Galleria mellonella (n = 10 per group). b An investigation was conducted on the survival of animals exposed to ellipticine in a highly FLC-tolerant C. albicans strain, cmp1-aidΔ/cmp1-aidΔ in Galleria mellonella (n = 10 per group). c The fungal load in the kidneys of phiKan 083 was conducted in C. albicans SN152 was assessed. n = 12 mice. d The CFUs analysis of phiKan 083 was conducted in the C. albicans strain cmp1-aidΔ/cmp1-aidΔ. n = 12 mice. e The histopathological examination of phiKan 083 in the C. albicans SN152 involved staining the kidneys of mice with PAS, followed by the display of representative images from 3 biological repeats. f The histopathological examination of phiKan 083 in the C. albicans strain cmp1-aidΔ/cmp1-aidΔ involved staining the kidneys of mice with PAS, followed by the display of representative images from 3 biological repeats. g An investigation into the survival of Galleria mellonella larvae (n = 10 per group) infected with the C. albicans SN152, specifically focusing on the impact of phiKan 083 treatment. h An investigation into the survival of Galleria mellonella larvae (n = 10 per group) infected with the highly FLC-tolerant C. albicans strain cmp1-aidΔ/cmp1-aidΔ, specifically focusing on the impact of phiKan 083 treatment. Data were presented as mean ± SD (c, d). Log-rank (Mantel-Cox) test (a, b, g, h), two-tailed unpaired t-test (c, d). Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 9 The schematic representation illustrates how the disruption of the Erg11-Ncp1 interaction increases the sensitivity of azoles. Ellipticine acts on Ncp1 to inhibit the Erg11-Ncp1 interaction within the ER, disrupting the electron transport chain between the two proteins. This disruption results in electron leakage, leading to the accumulation of excess electrons that react with oxygen to produce elevated levels of ROS. The surplus ROS oxidizes proteins synthesized in the ER, resulting in the production of misfolded proteins and the induction of ER stress. During ER stress, a substantial quantity of Ca2+ is transported from the ER to the cytoplasm, resulting in a notable elevation in cytoplasmic Ca2+ levels. The presence of a mitochondria-associated membrane (MAM) facilitates the transfer of Ca2+ from the ER to mitochondria. The buildup of Ca2+ in the mitochondria contributes to mitochondrial dysfunction and the advancement of cell apoptosis in C. albicans, thereby augmenting the efficacy of azoles.
Fig. 9 The schematic representation illustrates how the disruption of the Erg11-Ncp1 interaction increases the sensitivity of azoles. Ellipticine acts on Ncp1 to inhibit the Erg11-Ncp1 interaction within the ER, disrupting the electron transport chain between the two proteins. This disruption results in electron leakage, leading to the accumulation of excess electrons that react with oxygen to produce elevated levels of ROS. The surplus ROS oxidizes proteins synthesized in the ER, resulting in the production of misfolded proteins and the induction of ER stress. During ER stress, a substantial quantity of Ca2+ is transported from the ER to the cytoplasm, resulting in a notable elevation in cytoplasmic Ca2+ levels. The presence of a mitochondria-associated membrane (MAM) facilitates the transfer of Ca2+ from the ER to mitochondria. The buildup of Ca2+ in the mitochondria contributes to mitochondrial dysfunction and the advancement of cell apoptosis in C. albicans, thereby augmenting the efficacy of azoles.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

14 Valid · 1 Not valid · 2 Not checked · 86 Own results and interpretations

71 more claims · 2 with their cited sources checked

Create a free account to see all 103 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 10
  • It may state two separate claims as one. 19

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 70 references

Cited by

See all 13

Metadata

Authors
Li, W., Whiteway, M., Hang, S., Yu, J., Lu, H., & Jiang, Y.
Affiliations
  • Tongji University (CN)
  • Concordia University (CA)
Corresponding author
  • Lu, Hui
  • Jiang, Yuanying
Venue
Nature Communications
Published
2025-07-24
Volume
16
Issue
1
Pages
6821-6821
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4412631925
Cited by
13
References
68
Citations by year
2026: 13
FWCI
9.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (82020108032)
  • Shanghai Municipal Education Commission (202101070007E00094)
  • National Key Research and Development Program of China (2022YFC2303004)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Keywords
ERG11, NADPH-cytochrome P450 reductase, Candida albicans, fluconazole, ellipticine, protein-protein interaction, endoplasmic reticulum stress, reactive oxygen species, mitochondrial dysfunction, calcium release, apoptosis, antifungal resistance, candidiasis
MeSH terms
Animals, Antifungal Agents, Azoles, Calcium, Candida albicans, Candidiasis, Cytochrome P-450 Enzyme System, Endoplasmic Reticulum, Fungal Proteins, Microbial Sensitivity Tests, Mitochondria, NADPH-Ferrihemoprotein Reductase, Protein Binding, Fluconazole, Apoptosis, Reactive Oxygen Species, Drug Resistance, Fungal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles’ antifungal activities. https://app.cochat.ai/papers/10.1038/s41467-025-62131-z
The paper
Li, W., Whiteway, M., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2025). Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles’ antifungal activities. Nature Communications. https://doi.org/10.1038/s41467-025-62131-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.